Last Updated: May 3, 2026

Litigation Details for Orexo AB v. Actavis Elizabeth LLC (D. Del. 2017)

✉ Email this page to a colleague

« Back to Dashboard

Orexo AB v. Actavis Elizabeth LLC (D. Del. 2017)

Docket	⤷ Start Trial	Date Filed	2017-02-28
Court	District Court, D. Delaware	Date Terminated	2019-12-12
Cause	35:271 Patent Infringement	Assigned To	Colm Felix Connolly
Jury Demand	Plaintiff	Referred To
Patents	6,761,910; 8,454,996; 8,940,330
Link to Docket	External link to docket

Small Molecule Drugs cited in Orexo AB v. Actavis Elizabeth LLC

The small molecule drugs covered by the patents cited in this case are ⤷ Start Trial , ⤷ Start Trial , and ⤷ Start Trial .

Details for Orexo AB v. Actavis Elizabeth LLC (D. Del. 2017)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2017-02-28				External link to document
2017-02-28	160		Subutex® infringe United States Patent No. 8,454,996 ("the #996 patent"). In an earlier case filed…Robinson also held that U.S. Patent No. 8,940,330 ("the #330 patent") was invalid as obvious…the #330 patent does not implicate Judge Robinson's rulings with respect to the #996 patent. … generic version of Zubsolv® infringed the #996 patent. Orexo AB v. Actavis Elizabeth LLC, 217 F. Supp…Robinson ruled among other things that the #996 patent was valid and infringed by Actavis Elizabeth LLC	External link to document
2017-02-28	189		Defendants’2 products infringe U.S. Patent 8,454,996 (“the ’996 patent”). Fact and expert discovery are…certain claims in patents that cover technology incorporated into the standard. These patents are called ‘…essential patents.’” Id. at 1209. Organizations require owners of standard essential patents to grant…damages analysis. Dr. McDuff’s approach contradicts patent damages law, and his opinions on economic hold-…powder dosage form (which is encompassed by ’996 patent claim 2) or crushed slugs/tablets (in accordance	External link to document
2017-02-28	229		infringement and damages of United States Patent No. 8,454,996 (“the ’996 patent”). Attached hereto is a…Transcript (excerpt)  Exhibit R: U.S. Patent No. 8,454,996  Exhibit S: Dr. Davies’s Opening… 12 December 2019 1:17-cv-00205 830 Patent Plaintiff District Court, D. Delaware	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.